The effectiveness of Admira Protect (VOCO) for teeth hyperesthesia elimination as the first step of coordinated manipulations manifestation during the rehabilitation of patients with generalized parodontal disease

Abstract

Purpose: the evaluation of the clinical effectiveness of Admira Protect (VOCO) desensitiser to eliminate hypersensitivity while treatment of general parodontal disease.
Materials and methods. The clinical studies were performed amoung 39 patients aged from 25 to 44 years (24 women and 15 men) with different etiologies of teeth hyperesthesia. A 4 point scale was used to assess clinical effectiveness: 4 points for unbearable pain, 3 points for medium intensity pain, 2 points for mild pain and 1 point for no pain. The first pain sensitivity study was performed before the treatment (S1), the second one immediately after using Admira Protect (S2), the third control evaluation (СЕ 1) after 1 week, the fourth one (CE 2) after 1 month, the fifth one (CE 3) after 3 months. The assessment of oral cavity hygienic state was carried out using indexes: 1 – index O`Leary (%); 2 – IP1 (Silness-Loё); 3 – OHI-S (Greene-Vermillion). To estimate the intensity of parodontal inflammation the parodontal index –Ind. Russel – was used.
Results. After the first use of Admira Protect desensitiser for hyperesthesia, the pain reactions disappeared in 94 % of cases and the result remained stationary after a week had passed. The constant result was preserved during the control examination after 1 and 3 months. The analysis of parodontal condition revealed strongly marked and stable decrease of parodontal inflammation and improvement of oral hygiene. In the investigated group O`Leary index decreased for 56.5 % after 1 month, this means it made 43.5 % of pre-treatment index. The thickness of the plaque decreased for 51.2 % and its area for 66.2 %, as it was evidenced by IP1 and OHI-S. Ind. Russel decreased to 50.9 % and reached 49.1% of the original level. The persistent effect is observed 3 months after treatment – the index of O`Leary was 57.67 %, IP1 (Silness-Loё) – 56.44 % and OHI-S (Greene-Vermillion) was 44.97 % from the index before treatment. The Ind. Russel was below the baseline for 41.9 %. In comparison these indicators were much lower in the control group. Accordingly, in 1 month, the O`Leary index was already 81.14 %, IP1 (Silness-Loё) – 87.6 % and OHI-S (Greene-Vermillion) – 81.14 % of the pre treatment rates. The Ind. Russel decreased only for 24.6 % to 75.4 % of its original level. In 3 months, O`Leary index was 91.1 %, IP1 was 71.1 % and OHI-S was 91.7 % of pre-treatment indexes. The Ind. Russel was only 9.7 % below the baseline.
Conclusion. The Admira Protect desensitiser (VOCO) usage for the hyperesthesia treatment allows to eliminate completely or significantly reduce the hypersensitivity of teeth hard tissues after single use. This helps to improve cavity hygiene state and reduce the intensity of inflammation. The elimination of teeth hyperaesthesia is the first step to «disease management» during the rehabilitation of patients with generalized parodontal disease. This will increase patient’s confidence, will make many therapeutic and preventive manipulations easier, and promote better communication between patient and doctor during the treatment.
Key words: hypersensitivity of teeth hard tissues, generalized parodontal disease, desensitisers, «disease management».